News

Filter

Isis Pharma teams up with Janssen on autoimmune disorders in the GI tract

05-01-2015

Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech, a unit of US health…

BiotechnologyGastro-intestinalsIsis PharmaceuticalsJanssen BiotechJohnson & JohnsonLicensingResearch

US FDA approves Janssen's Simponi to treat ulcerative colitis

16-05-2013

The US Food and Drug Administration late yesterday (May 15) approved a new use for Johnson & Johnson…

BiotechnologyGastro-intestinalsInflammatory diseasesJanssen BiotechJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSimponi Injection

Back to top